BourneG.H.: The Biochemistry and Physiology of Bone, 2nd ed, London: Academic Press, 1972.
2.
FrostH.M.: Bone Remodeling Dynamics, Springfield, Ill: Charles C Thomas, 1963.
3.
HarrisW.H., and HeaneyR.P.: Skeletal Renewal and Metabolic Bone Disease, N Eng J Med280: 193–202, 253-259, 303-311, 1969.
4.
RasmussenH., and BordierP.: The Cellular Basis of Metabolic Bone Disease, N Engl J Med289: 25–32, 1973.
5.
JettS.; DuncanH.; and FrostH.M.: Adrenalcorticoid and Salicylate Actions on Human and Canine Haversian Bone Re-modeling, Clin Orthop, 68:301–315, 1970.
6.
BelangerL.F.; RobichonJ.; MigicovskyB.B.; CoppD.H.; and VincentJ.: Resorption Without Osteoclasts (Osteolysis), in Mechanisms of Hard Tissue Destruction, Washington: American Association for the Advancement of Science, 1963, p 531.
7.
BaylinckD.J.; MoreyE.; and RichC.: Effect of Calcitonin on Osteocyte Mineral Transfer in the Rat, in Parathyroid Hormone and Thyrocalcitonin (Calcitonin), Amsterdam: Excerpta Medica, 1968, p 196.
8.
HoltropM.E., and WeingerJ.M.: Ultrastructural Evidence for a Transport System in Bone, in Calcium, Parathyroid Hormone and the Calcitonins, Amsterdam: Excerpta Medica, 1972, p 365.
9.
BordierP.J., and Tun ChotS.: Quantitative Histology of Metabolic Bone Disease, Clin Endocrinol Metabol1: 197–215, 1972.
10.
HirschP.F., and MunsonP.L.: Thyro-calcitonin, Physiol Rev49: 548–622, 1968.
11.
CochranM.; PeacockM.; SachsG.; and NordinB.E.C.: Renal Effects of Calcitonin, in Calcitonin, 1969 Proceedings of the Second International Symposium, London: Heineman, 1970, p 523.
12.
BijvoetO.L.M.; Van Der Sluys VeerJ.; GrevenH.M.; and SchellekensA.P.M.: Influence of Calcitonin on Renal Excretion of Sodium and Calcium, in Calcium, Para-thyroid Hormone and the Calcitonins, Amsterdam: Excerpta Medica, 1972, p 284.
13.
WenerJ.A.; GortonS.J.; and RaiszL.G.: Escape from Inhibition of Resorption in Cultures of Fetal Bone Treated with Calcitonin and Parathyroid Hormone, Endocrinology90: 752–759, 1972.
14.
RaiszL.G.; AuW.Y.W.; FriedmanJ.; and NiemannI.: Thyrocalcitonin and Bone Resorption, Am J Med43: 684–690, 1967.
15.
FriedmanJ.; AuW.Y.W.; and RaiszL.G.: Responses of Fetal Rat Bone to Thyrocal-citonin in Tissue Culture, Endocrinology82: 149–156, 1968.
16.
RaiszL.G.; TrummelC.L.; WenerJ.A.; and SimmonsH.: Effect of Glucocorticoids on Bone Resorption in Tissue Culture, Endocrinology90: 961–967, 1972.
17.
RaiszL.G.; TrummelC.L.; and SimmonsH.: Induction of Bone Resorption in Tissue Culture: Prolonged Response after Brief Exposure to Parathyroid Hormone or 25-Hydroxycholecalciferol, Endocrinology90: 744–751, 1972.
18.
HamiltonC.R.: Effects of Synthetic Salmon Calcitonin in Patients with Paget's Disease of Bone, Am J Med56: 315–322, 1974.
19.
GershbergH.; GirgisM.; GoldbergL.; DugaJ.; and ST. PaulH.: The Acute Respone to Calcitonin in Paget's Disease: Its Relationship to the Serum Alkaline Phos-phatase Level and the Effect of Phosphate Treatment, J Clin Endocrinol Metab36: 691–696, 1973.
20.
KallioD.M.; GarantP.R.; and MinkinC: Ultrastructural Effects of Calcitonin on Osteoclasts in Tissue Culture, J Ultrastruct Res39: 205–216, 1972.
21.
KraneS.M.; HarrisE.D.; SingerF.R.; and PottsJ.T.Jr.: Acute Effects of Calcitonin on Bone Formation in Man, Metabolism22: 51–58, 1973.
22.
BluntJ.W.; DE LucaH.F.; and SchnoesH.K.: 25-Hydroxycholecalciferol. A Biologically Active Metabolite of Vitamin D3, Biochemistry7: 3317–3322, 1968.
23.
LawsonD.E.M.; FraserD.R.; KodicekE.; MorrisH.R.; and WilliamsD.H.: Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone Controlling Calcium Metabolism, Nature (Lond)230: 228–230, 1971.
24.
HolickM.F.; SchnoesH.F.; and DE LucaH.F.: Identification of 1,25-Dihydroxychole-calciferol, a Form of Vitamin D3 Metabolically Active in the Intestine, Proc Nat Acad Sci Usa68: 803–804, 1971.
25.
NormanA.W.; MyrtleJ.F.; MidgettR.J.; NorwickiH.G.; WilliamsV.; and PopjakG.: 1,25-Dihydroxycholecalciferol: Identification of the Proposed Active Form of Vitamin D3 in the Intestine, Science173: 51–54, 1971.
26.
KodicekE.: The Story of Vitamin D from Vitamin to Hormone, Lancet1: 325–329, 1974.
27.
BoyleI.T.; GrayR.W.; OmdahlJ.L.; and DE LucaH.F.: Calcium Control of the In Vivo Biosynthesis of 1,25-Dihydroxyvitamin D3 Nicolaysen's Endogenous Factor, in Endocrinology, 1971 Proceedings of the Third International Symposium, London: Heinmann, 1972, p 468.
28.
LarkinsR.G.; MacauleyS.J.; ColstonK.W.; EvansI.M.A.; GalanteL.S.; and MacintyreI.: Regulation of Vitamin D Metabolism without Parathyroid Hormone, Lanct2: 289–291, 1973.
29.
GarabadianM.; HolickM.F.; DE LucaH.F.; and BoyleI.T.: Control of 25-Hydroxycholecaliferol Metabolism by Parathyroid Glands, Proc Nat Acad Sci Usa, 69: 1673–1676, 1972.
30.
FraserD.R., and KodicekE.: Regulation of 25-Hydroxycholecalciferol-l-Hydroxylase Activity in Kidney by Parathyroid Hormone, Nature (New Biol)241: 163–166, 1973.
31.
TanakaY., and DE LucaH.F.: The Control of 25-Hydroxyvitamin D Metabolism by Inorganic Phosphorus, Arch Biochem Biophys154: 566–574, 1973.
32.
HolickM.F.; SchnoesH.K.; DE LucaH.F.; GrayR.W.; BoyleI.T.; and SudaT.: Isolation and Identification of 24, 25-Dihydroxycholecalciferol, a Metabolite of Vitamin D3 Made in the Kidney, Biochemistry11: 4251–4255, 1972.
33.
HolickM.F.; Kleiner-BossallerA.; SchnoesH.K.; KastenP.M.; Boyle, LT.;, and DE LucaH.F.: 1,24,25-Trihydroxyvita-min D3. A Metabolite of Vitamin D3 Effective on Intestine, J Biol Chem248: 6691–6696, 1973.
34.
RaiszL.G., and TrummelC.L.: Effect of Vitamin D Metabolites on Bone Resorption in Tissue Culture, in Endocrinology, 1971 Proceedings of the Third International Symposium, London: Heinmann, 1972, p 480.
35.
ReynoldsJ.J.; HolickM.F.; and DE LucaH. F.: The Role of Vitamin D Metabolites in Bone Resorption, Calcif Tissue Res12: 295–301, 1973.
36.
TanakaY., and DE LucaH.F.: Bone Mineral Mobilization Activity of 1,25-Dihydroxy-cholecalciferol, a Metabolite of Vitamin D, Arch Biochem Biophys146: 574–578, 1971.
37.
WeberJ.C.; PonsV.; and KodicekE.: The Localization of 1,25-Dihydroxycholecalciferol in Bone Cell Nuclei of Rachitic Chicks, Biochem J125: 147–153, 1971.
38.
BrickmannA.S.; CoburnJ.W.; and Nor-ManA.W.: Action of 1,25-Dihydroxychole-calciferol, a Potent Kidney Produced Metabolite of Vitamin D, in Uremic Man, N Eng J Med287: 891–895, 1972.
39.
HendersonR.G., LedinghamJ.G.G.; OliverD.O.; SmallD.G.; RusselR.G.G.; SmithR.; WaltonR.J.; PrestonC.; WarnerG.T.; and NormanA.W.: Effects of 1,25-Dihydroxycholecalciferol on Calcium Absorption, Muscle Weakness, and Bone Disease in Chronic Renal Failure, Lancet1: 379–384, 1974.
40.
BrickmanA.S.; CoburnJ.W.; MassryS.G.; and NormanA.W.: 1,25-Dihydroxy-Vitamin D3 in Normal Man and Patients with Renal Failure, Ann Intern Med80: 161–168, 1973.
41.
HolickM.F.; SemmlerE.J.; SchnoesH.K.; and DE LucaH.F.: 1α-Hydroxy Derivative of Vitamin D3: A Highly Potent Analogue of 1α,25-Dihydroxyvitamin D3, Science180: 190–191, 1973.
42.
PeacockM.; GallagherJ.C.; and NordinB.E.C.: Action of 1α-Hydroxy Vitamin D3 on Calcium Absorption and Bone Resorption in Man, Lancet1: 385–389, 1974.
43.
HausslerM.R.; ZerwekhJ.E.; HesseR.H.; RizzardoE.; and PechetM.M.: Biological Activity of 1α-Hydroxycholecalciferol, a Synthetic Analog of the Hormonal Form of Vitamin D3, Proc Nat Acad Sci, Usa70: 2248–2252, 1973.
44.
SherwoodL.M.; O'RiordanJ.L.H.; AurbachG.D.; and PottsJ.T.Jr.: Production of Parathyroid Hormone by Nonparathyroid Tumors, J Clin Endocrinol Metab27: 140–146, 1967.
45.
BersonS.A., and YallowR.S.: Parathyroid Hormone in Plasma in Adenomatous Hyperparathyroidism, Uremia, and Broncho-genic Carcinoma, Science154: 907–908.
46.
RiggsB.L.; ArnaudC.D.; ReynoldsJ.C.: Immunologic Differentiation of Primary Hyperparathyriodism from Hyperparathyroid-ism due to Nonparathyroid Cancer, J Clin Invest50: 2079–2083, 1971.
47.
GordanG.S.; CantinoT.J.; ErhardtL.; HansenJ.; and LubichW.: Osteolytic Sterol in Human Breast Cancer, Science151: 1226–1228, 1966.
48.
PowellD.; SingerF.R.; MurrayT.M.; MinkinC.; and PottsJ.T.Jr.: Nonpara-thyroid Humoral Hypercalcemia in Patients with Neoplastic Diseases, N Engl J Med289: 176–181, 1973.
49.
GoldhaberP.: Enhancement of Bone Resorption in Tissue Culture by Mouse Fibro-sarcoma, Proc Am Assoc Cancer Res3: 113, 1960.
50.
VoelkelE.F.; TashjianA.H.Jr.; and GoldhaberP.: A Non-peptide Factor Produced by Fibrosarcoma Cells that Stimulates Bone Resorption in Organ Culture, in Calcium, Parathyroid Hormone and the Cal-citonins, Amsterdam: Excerpta Medica, 1972, p 478.
51.
KleinD.C., and RaiszL.G.: Prostaglandins: Stimulation of Bone Resorption in Tissue Culture, Endocrinology86: 1436–1440, 1970.
52.
LevignL.; HinkleP.M.; VoelkelE.F.; and TashjianA.H.Jr.: Prostaglandin Production by Mouse Fibrosarcoma Cells in Culture: Inhibition by Indomethacin and Aspirin, Biochem Biophys Res Commun47: 888–896, 1972.
53.
TashjianA.H.Jr.; VoelkelE.F.; LevignL.; and GoldhaberP.: Evidence that the Bone Resorption-Stimulating Factor Produced by Mouse Fibrosarcoma Cells is Prostaglandin E2. A New Model for the Hyper-calcemia of Cancer, J Exp Med136: 1329–1343, 1972.
54.
TashjianA.H.Jr.; VoelkelE.F.; Gold-HaberP.; and LevignL.: Prostaglandins, Calcium Metabolism and Cancer, Fed Proc33: 81–86, 1974.
55.
BelielO.M.; SingerF.R.; and CoburnJ.W.: Prostaglandins: Effect on Plasma Calcium Concentration, Prostaglandins3: 237–241, 1973.
56.
PoyserN.L.: The Physiology of Prosta-glandins, Clin Endocrinol Metabol2: 393–410, 1973.
57.
TashjianA.H.Jr.: Tumor Humors and the Hypercalcemia of Cancer, N Eng J Med290: 905–906, 1974.
58.
GoldhaberP.; RabadjijaL.; BeyerW.R.; and KorhauserA.: Bone Resorption in Tissue Culture and its Relevance to Periodontal Disease, JADA87: 1027–1033, 1973.
59.
SaccoR.; HausmannE.; and GencoR.: Immunologically Activated Factors: Stimulation of Bone Resorption in Tissue Culture, abstracted, IADR Program and Abstracts of Papers, No. 370, 1972.
60.
HausmannE.; RaiszL.G.; and MillerW.A.: Endotoxin: Stimulation of Bone Resorption in Tissue Culture, Science168: 862–864, 1970.
61.
HortonJ.E.; LeikenS.; and OppenheimJ.J.: Human Lymphoproliferative Reaction to Saliva and Dental Plaque Deposits: An In Vitro Correlation with Periodontal Disease, J Periodontal43: 522–527, 1972.
62.
HortonJ.E.; RaiszL.G.; SimmonsH.A.; OppenheimJ.Jr; and MergenhagenS.E.: Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood Leukocytes, Science177: 793–795, 1972.
63.
HortonJ.E.; OppenheimJ.J.; and MergenhagenS.E.: Elaboration of Lymphotoxin by Cultured Human Peripheral Blood Leucocytes Stimulated with Dental Plaques Deposits, Clin Exp Immunol13: 383–393, 1973.
64.
MundyF.R.; LubenR.A.; RaiszL.G., OppenheimJ.J.; and BuellD.N.: Bone-Resorbing Activity in Supernatants from Lymphoid Cell Lines, N Eng J Med290: 867–871, 1974.